Endostar Combined With SBRT and Envafolimab in the Treatment of Advanced Gastrointestinal Tumors

NCT06301828 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Gastrointestinal Neoplasms

Interventions

DRUG: Envafolimab Injection
DRUG: Endostar

Sponsor

Nanjing First Hospital, Nanjing Medical University